Explore more about: Mental Health

The National Institutes of Health, through its Blueprint MedTech program, has established two incubator hubs and launched a funding solicitation in support of commercially viable, clinically focused neurotechnology solutions to diagnose and treat disorders of the nervous system.

Research into what is known as the gut-brain axis continues to reveal how the brain and gut influence each other’s health and well-being. Now researchers are endeavoring to learn more about gut-brain discourse using a model system built in a lab dish.

Marking a major milestone on the path to meeting the objectives of the NIH BRAIN initiative, researchers advance high-density electroencephalography (EEG) as the future paradigm for dynamic functional neuroimaging.

With his election this past February to the National Academy of Engineering (NAE), NIH’s Peter Basser achieved one of the highest professional distinctions accorded to any engineer.

After a patient swallows anordinary-looking capsule, the star’s six arms unfold inside the stomach and steadily release ingredients for a week; then the arms break off and leave the body like undigested food. The pill can deliver a variety of prescription medicines.

Electrically stimulating nerves can reduce epileptic seizures, soothe chronic pain, and treat depression. Now, biomedical engineers have made a significant advance that could dramatically reduce the cost of neuromodulation therapy, increase its reliability and make it much less invasive.

A study evaluated the relationship between schizophrenia genes and those associated with subcortical brain volumes, and found no genetic overlap between them.